The use of robotically assisted hysterectomy has become more frequent since the FDA approved the use of the robotic surgical platform for gynecologic procedures. Although robotic surgery is more costly, a recent study has shown that the outcomes for robotic surgery are not superior to open abdominal, vaginal and laparoscopic surgery for benign disease. The study looked at 275,000 cases at 441 hospitals between 2007 to 2010 and compared the rate of intra-operative complications, surgical site complications, medical complications, transfusion requirements, reoperation rates and mortality. Robotically assisted surgery did not significantly improve outcomes or reduce complications. The frequency of abdominal and vaginal approaches for hysterectomy declined from 54% to 41% of cases and from 22% to 20% respectively. The frequency for laparoscopic hysterectomy rose from 24% to 30%. But the frequency for robotic surgery skyrocketed from 0.5% to 30% of procedures during the study.